MICREOS

micreos-logo

According to the World Health Organization (WHO) emergence of antibiotic-resistant 'superbugs' is now a global concern, which can spell the end of modern medicine and a return to the days when routine operations, simple wounds or straightforward infections were potentially life-threatening. On the other hand scientists have come to realize that the vast majority of bacteria is beneficial and should be left intact. Antibiotics do not distinguish between bad and good bacteria and their use can... lead to side effects and resistance. Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. With Micreos' endolysin technology, for the first time it is possible to kill only the unwanted bacteria - including antibiotic resistant strains such as MRSA - while leaving our microbiome - comprising billions of beneficial bacteria on our skin and in our gut - intact. In addition, research shows that the use of endolysins does not induce resistance. This unlocks a completely new approach in dealing with the bacteria around us: killing the bad bacteria and preserving the microbiome. Micreos' Staphefekt SA.100 is an enzyme (endolysin), that targets only Staphylococcus aureus. Marketed under the Gladskin brand, it is the world's first endolysin registered for human use and has had a life-changing impact for thousands of people suffering from inflammatory skin conditions such as eczema, inflammatory acne and rosacea and resistant wound infections (see www.gladskin.com). A series of pharmaceutical products based on the endolysin XZ.700 - also targeting S. aureus - is in clinical development. First indications include: atopic dermatitis, diabetic wound infections and folliculitis. Micreos has also developed FDA-approved food safety products: 'Phageguard S' against Salmonella and 'Phageguard L' against Listeria monocytogenes, which is especially dangerous for pregnant women and for the elderly and immuno-compromised (www.phageguard.com).

#SimilarOrganizations #People #Financial #Event #Website #More

MICREOS

Social Links:

Industry:
Biotechnology Health Care Product Design Product Research

Founded:
2006-01-01

Address:
Wageningen, Gelderland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.micreos.com

Total Employee:
51+

Status:
Active

Contact:
31 31 742 1414

Email Addresses:
[email protected]

Total Funding:
80.81 M USD

Technology used in webpage:
Google Tag Manager ReCAPTCHA ReCAPTCHA V2 ASP.NET Ajax


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

phico-therapeutics-logo

Phico Therapeutics

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

Current Employees Featured

mark-offerhaus_image

Mark Offerhaus
Mark Offerhaus CEO and founder @ Micreos
CEO and founder
2005-01-01

joost-goderie_image

Joost Goderie
Joost Goderie CFO and member of the Board of Directors @ Micreos
CFO and member of the Board of Directors
2021-07-01

not_available_image

Johan Frieling
Johan Frieling CMO @ Micreos
CMO

pierre-jeremy-gardiner_image

Pierre-Jeremy Gardiner
Pierre-Jeremy Gardiner Gladskin Country Manager France @ Micreos
Gladskin Country Manager France
2022-04-01

carsten-edwards_image

Carsten Edwards
Carsten Edwards Chief Development Officer @ Micreos
Chief Development Officer
2022-04-01

trine-ahlgreen_image

Trine Ahlgreen
Trine Ahlgreen Chief Business Officer @ Micreos
Chief Business Officer
2022-04-01

barry-r-frankel_image

Barry R. Frankel
Barry R. Frankel Strategic Advisor @ Micreos
Strategic Advisor
2021-01-01

matt-regan_image

Matt Regan
Matt Regan CEO of its Pharmaceutical business @ Micreos
CEO of its Pharmaceutical business
2021-10-01

not_available_image

Michael Riedlin
Michael Riedlin COO @ Micreos
COO

not_available_image

Reinier Noort
Reinier Noort CFO @ Micreos
CFO

Founder


hans-poul-veldhuyzen-van-zanten_image

Hans-Poul Veldhuyzen van Zanten

mark-offerhaus_image

Mark Offerhaus

Investors List

horizon-2020_image

Horizon 2020

Horizon 2020 investment in Grant - Micreos

ministry-of-economic-affairs-innovation-credit_image

Ministry of Economic Affairs (Innovation Credit)

Ministry of Economic Affairs (Innovation Credit) investment in Grant - Micreos

Official Site Inspections

http://www.micreos.com Semrush global rank: 6.96 M Semrush visits lastest month: 670

  • Host name: crantock.cloudabove.com
  • IP address: 185.219.238.47
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Micreos" on Search Engine